The application of PI3K inhibitors in GBM is actively researched, as the PI3K/AKT/mTOR pathway is often hyperactivated in GBM and critical for tumor growth, survival, migration, and invasion [48]. This evidence concerns the gene AKT1 and glioblastoma.